Statistics for Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity - 27 month follow-up results from Turkey.

Total visits

views
Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity - 27 month follow-up results from Turkey. 0

Total visits per month

views
September 2023 0
October 2023 0
November 2023 0
December 2023 0
January 2024 0
February 2024 0
March 2024 0